Call for Abstract
World Oncologists Annual Conference, will be organized around the theme “Shaping the Future of Cancer care”
World Oncologists 2018 is comprised of 16 tracks and 0 sessions designed to offer comprehensive sessions that address current issues in World Oncologists 2018.
Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
The genetic changes that contribute to cancer tend to affect three main types of genes - proto oncogenes, tumor suppressor genes, and DNA repair genes. These changes are sometimes called “drivers” of cancer. Proto-oncogenes are involved in normal cell growth and division. However, when these genes are altered in certain ways or are more active than normal, they may become cancer-causing genes (or oncogenes) allowing cells to grow and survive when they should not. Tumor suppressor genes are also involved in controlling cell growth and division. Cells with certain alterations in tumor suppressor genes may divide in an uncontrolled manner. DNA repair genes are involved in fixing damaged DNA. Cells with mutations in these genes tend to develop additional mutations in other genes. Together, these mutations may cause the cells to become cancerous. The process by which cancer cells spread to other parts of the body is called metastasis. Metastatic cancer spreads from the part of the body where it originated (the primary site) to other parts of the body. A risk factor is anything that increases a person’s chances of developing a Tumor. Although factors often influence the development of a tumor, most do not directly cause it. Some people with several risk factors never develop a tumor, while others with no known risk factors do. Some risk factors are as Age, Gender, Race/Ethnicity, Family history, Immune system suppression, arsenic exposure. Generally, the cause of Cancer is unknown. People who have one of the rare family syndromes have a higher risk of developing Tumors.
Cancer staging is the process of determining how much the cancer has spread out inside the body and where it is located. Staging describes the severity of an individual's cancer based on the magnitude of the original (primary) tumor as well as on the extent the cancer has spread in the body. Understanding the stage of the cancer helps doctors to develop a prognosis and design a treatment plan for individual patients.
The phenomenon of Cancer cells spreading to other parts of the body is called metastasis. Metastatic cancer has spread from the part of the body where it started (the primary site) to other parts of the body. There are a number of different types of Cancer. They are generally are called after the organ or type of cell they develop in the beginning, Medical Illustrations, Risk Factors, Prevention, Symptoms & Signs, Diagnosis, Stages, Treatment Options, About Clinical Trials, Latest Research, Coping with Treatment, Follow-Up Care, Survivorship, The American Society of Clinical Oncology (ASCO) believes that all treatment decisions should be made between patients and their doctors. Tumor most often develops in the gut or pancreas. These tumors are sometimes grouped together and called gastroenteropancreatic neuroendocrine tumors or GEP NETs in short. NETs of the gut are most often carcinoid tumors. They may also just be called carcinoid. NETs that develop in the pancreas are also called endocrine tumors of the pancreas. Some of these tumors can also develop outside the pancreas. For example, gastrinomas have been reported in the medical literature to develop in the ovaries, kidneys, stomach and liver, and not just in the pancreas and small bowel area. Common types of Cancer which are diagnosed most often are Breast Cancer, Bladder Cancer, Colorectal Cancer, Kidney Cancer, Lung Cancer, Lymphoma, Melanoma, Oral and Oropharyngeal Cancer, Pancreatic, Prostate, Thyroid, Uterine Cancer.
Hematologic cancers affect he production and function of ones’ blood cells. Most of these cancers originate in the bone marrow where blood is produced. Stem cells in the bone marrow mature and develop into three types of blood cells: red blood cells, white blood cells, or platelets. In most blood cancers, the normal blood cell development process is interrupted by uncontrolled growth of an abnormal type of blood cell. These abnormal blood cells, or cancerous cells, prevent the blood from performing many of its functions, like fighting off infections or preventing serious bleeding.
Head and Neck cancers usually begin in the squamous cells that line the moist, mucosal surfaces inside the head and neck (for example, inside the mouth, the nose, and the throat). These squamous cell cancers are often referred to as squamous cell carcinomas of the head and neck. Head and neck cancers can also develop in the salivary glands, but salivary gland cancers are relatively uncommon. Salivary glands contain different types of cells that can become cancerous, so there are many different types of salivary gland cancer. Cancers of the head and neck are further categorized by the area of the head or neck in which they begin from oral cavity, pharynx, larynx, Para-nasal sinuses and nasal cavity, salivary glands.
Neuro-oncology is the study of brain and spinal cord neoplasms, many of which are (at least eventually) very dangerous and life-threatening (astrocytoma, glioma, giloblastoma, multiforme, ependymoma, pontneglioma, and brain stem tumors are among the many examples of these). Among the malignant brain cancers, gliomas of the brainstem and pons, glioblastoma multiforme, and high-grade (highly anaplastic) astrocytoma are among the worst. In these cases, if untreated life span usually amounts to only a few months, and survival with current radiation and chemotherapy treatments may extend that time from around a year to a year and a half, possibly two or more, depending on the patient's condition, immune function, treatments used.
An endocrine tumor is a growth that affects the parts of the body that secrete hormones. Because an endocrine tumor arises from cells that produce hormones, the tumor itself can produce hormones. These hormones are produced in excessive amounts by endocrine tumors and then released into the blood. The excessive amounts of hormones in the blood produce marked abnormal effects on the body. A neuroendocrine tumor begins in the area showing combination of hormone-producing endocrine cells and nerve cells. Neuroendocrine cells are found throughout the body in organs such as the lungs and gastrointestinal tract, including the stomach and intestines. Neuroendocrine cells perform specific functions, such as regulating air and blood flow through the lungs and controlling how quickly food moves through the gastrointestinal tract. They are other types of tumors in endocrine and neuroendocrine tumors.
Breast cancer can begin in different areas of the breast; the ducts, the lobules, or in some cases, the tissue in between. In this section, we could include the different types of breast cancer, including non-invasive, invasive, recurrent, and metastatic breast cancers. Breast cancer is a phenomena that can even occur in men. Breast tissue contains fat and connective tissue, lymph nodes and blood vessels, they are made up of glands called tubules that can produce milk and thin tubes called ducts that carry the milk to the nipple. The most common type of breast Cancer is ductal Carcinoma. Breast Cancer can also begin in the cells of the lobules in other tissues in the breast.
Reproductive Cancers are those Cancers that occur in the reproductive organs of both Women and Men. In Women, these are Cancers that commonly occur in the breast, cervix, vulva, endometrium or Ovaries. In men reproductive Cancer can be found in the prostate, testicles, and penis.
The immune system’s natural capacity to detect and destroy abnormal cells may prevent the development of many cancers. However, cancer cells are sometimes able to avoid detection and destruction by the immune system. The latest exciting research breakthrough for cancer treatment is immune-oncology. This type of treatment enhances the patient’s own immune system to stop the growing cancer cells. This treatment is with the T-cells. These T-cells usually recognize cancer cells as being foreign and attack those cells. In this treatment the drugs will suppress the PD-L1 molecule that is available on the surface of the cancer cell and that will allow the T-cell to attack that cancer cells. The current research is mainly going on the Immuno-Oncology way with good growth rate and treatment success.
Surgery is the main treatment in nearly every case of cancer, and it is the main treatment for both pheochromocytoma and Merkel cell cancer. During surgery, the doctor removes the tumor along with a small border of healthy tissue around the tumor, called a margin For pheochromocytoma, laparoscopic surgery may be performed. Laparoscopic surgery is a less invasive type of surgery that uses three or four small incisions instead of one large incision. A thin, lighted tube called a laparoscope that is attached to a video camera is inserted through one opening to guide the surgeon. Surgical instruments are inserted through the other openings to perform the surgery. If removing the tumor using surgery is not possible, it is called an inoperable tumor, and the doctor will recommend another type of treatment. The patient candidate forsurgery does not depend on factors such as the type, size, location, grade and stage of the Tumor along with the consideration of the general health factors like age, physical fitness and other coexisting medical conditions. Surgery will be combined with other Cancer treatments, such as chemotherapy, Radiation therapy or hormone therapy in some Cases.
Radiation Medicine is a process in which they use high-energy radiation, in the form of waves or particles, to destroy cancer cells by damaging their DNA. Because radiation can harm healthy cells, treatment must be carefully planned and precisely conducted to minimize side effects. Radiation therapy may be given before, during, or after other therapies in your treatment plan. It may be used alone or with other treatments to destroy cancer cells, shrink tumors, prevent recurrence and relieve symptoms caused by the cancer, such as pain. The Radiation team plans the treatment by choosing the type, dose and area where the radiation therapy is to be performed. Internal radiation (these include different radioactive materials like seeds, beads, wires or other radioactive substances for the treatment by placing them within the body near the cancer cells. People involved in radiation medicine are Medical Physicist, Radiation Oncologist, Dosimetrist, Radiation Therapist.
Biomarkers have a greater role in the study of cancer, which involves the risk assessment, screening, diagnosis, prognosis, prediction of the treatment response, and monitoring of the progression of the disease. As the biomarkers play an important role in every condition of the disease, the biomarkers is evaluated accurately, including analytical validation, clinical validation and clinical utility assessment, incorporating routine clinical care. Cancer Biomarkers are also useful in the process of developing drug targets that makes it easy to deliver the drugs.
Nuclear medicine imaging uses small amounts of radioactive materials called radiotracers that are typically injected into the blood stream, inhaled or swallowed. The radiotracer travels through the area being examined and gives off energy in the form of gamma rays which are detected by a special camera and a computer to create images of the inside of your body. Nuclear medicine imaging provides unique information that often cannot be obtained using other imaging procedures and offers the potential to identify disease in its earliest stages.
Doctors and scientists are always looking for better ways to treat patients with tumor. To make scientific advances, doctors create research studies involving volunteers, called clinical trials. Many clinical trials are focused on new treatments, evaluating whether a new treatment is safe, effective, and possibly better than the current (standard) treatment. These types of studies evaluate new drugs, different combinations of existing treatments, new approaches in radiation therapy or surgery, and new methods of treatment. Patients who participate in clinical trials are often among the first to receive new treatments before they are widely available. However, there is no guarantee that the new treatment will be safe, effective, or better than a standard treatment. There are also clinical trials that study new ways to ease symptoms and side effects during treatment and managing the late effects that may occur after treatment.
Recent progress in biological therapies has widened the scale of therapeutic targets for treatment of cancer with the identification of tumor cell specific genes. Imm0075notherapies/ biologics are emerging as potential therapies to find a permanent cure for various cancer types. Amongst various biologics, drugs based on monoclonal antibodies (mAbs) have gained significant attention in recent years due to their high efficacy. Global cancer drugs market accounted for $78,238.9 million in 2015, and is forecast to generate a revenue of $111,938.4 million by 2020.